文献速递创伤与烧伤重症综合管理与镇静镇痛

智能计算法评估危重创伤患者早期肝损伤风险:一项回顾性研究

[Early liver injury risk assessment in critically injured trauma patients using intelligent calculation method: a retrospective study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论危重创伤患者早期肝酶升高常见且可逆,APACHE II>15者6小时内ALT、AST异常率及水平更高。

该回顾性研究纳入2022年1月1日至2023年12月1日天津市第五中心医院急诊医学中心收治的112例危重创伤患者(ISS≥16,年龄>18岁),用智能计算法于入急诊时采集ISS和APACHE II评分,分析入科后6、24、72小时空腹静脉血清ALT、AST、ALP、GGT、LDH、ALB、TBil、PT变化趋势。结果显示入科6小时内LDH、AST、ALT升高比例分别为77.68%、79.46%、52.68%,ALB降低比例75.89%,ALP、GGT、TBil、PT异常率均低于50%;24小时和72小时ALT、AST均显著低于6小时。按APACHE II>15(45例)与≤15(67例)分组,两组ISS无显著差异,但APACHE II>15组6小时内ALT、AST异常率及水平均更高(均P<0.05)。作者认为危重创伤患者早期肝功能损害发生率高且可逆,联合ISS与APACHE II评分在评估早期肝损伤方面具有明显优势。

要点

  • 危重创伤患者(ISS≥16,年龄>18岁)入科6小时内LDH升高77.68%、AST升高79.46%、ALT升高52.68%,ALB降低75.89%。
  • 入科24小时和72小时ALT、AST均显著低于6小时[ALT 37.0(22.0, 66.0)、31.0(21.2, 52.0)vs. 41.0(25.0, 71.0)U/L;AST 55.5(30.0, 93.5)、40.0(27.0, 63.2)vs. 69.5(39.0, 130.8)U/L,均P<0.05]。
  • APACHE II>15组(45例)与≤15组(67例)ISS无显著差异[21.0(18.5, 26.5)vs. 20.0(17.0, 22.0),P>0.05]。
  • APACHE II>15组6小时内ALT异常率66.44%(29/45)vs. 44.78%(30/67)、AST异常率93.33%(42/45)vs. 70.15%(47/67),均P<0.05。
  • APACHE II>15组6小时内ALT、AST水平更高[ALT 56.0(30.0, 121.0)vs. 35.0(21.0, 69.0)U/L,AST 87.0(48.0, 233.0)vs. 52.0(31.0, 117.0)U/L,均P<0.05]。

适用人群与场景

  • 2022年1月1日至2023年12月1日天津市第五中心医院急诊医学中心收治的危重创伤患者,ISS≥16,年龄>18岁。
  • 损伤原因以道路交通伤最常见(68例,60.71%),其次为高处坠落伤、挤压伤、重物伤、刀刺伤、爆炸伤。
  • 损伤部位以四肢和骨盆最常见(97例,86.61%),其次为胸部损伤、体表皮肤软组织损伤、腹部和盆腔脏器损伤、颅脑损伤、面部损伤。

诊断标准与关键阈值

  • 危重创伤定义:损伤严重度评分(ISS)≥16分。
  • 分组阈值:按APACHE II评分分为APACHE II>15组(45例)与APACHE II≤15组(67例)。

研究设计与关键结果

  • 研究类型:回顾性研究;样本量112例,男83例、女29例,平均年龄(47.78±14.84)岁,ISS中位数21.0(18.0, 26.0)。
  • 入科6小时内LDH升高77.68%、AST升高79.46%、ALT升高52.68%,ALB降低75.89%;ALP、GGT、TBil、PT异常率均低于50%。
  • 入科24小时和72小时ALT、AST均显著低于6小时[ALT 37.0(22.0, 66.0)、31.0(21.2, 52.0)vs. 41.0(25.0, 71.0)U/L,AST 55.5(30.0, 93.5)、40.0(27.0, 63.2)vs. 69.5(39.0, 130.8)U/L,均P<0.05]。
  • APACHE II>15组与≤15组ISS无显著差异[21.0(18.5, 26.5)vs. 20.0(17.0, 22.0),P>0.05]。
  • APACHE II>15组6小时内ALT异常率66.44%(29/45)vs. 44.78%(30/67)、AST异常率93.33%(42/45)vs. 70.15%(47/67),均P<0.05;ALT 56.0(30.0, 121.0)vs. 35.0(21.0, 69.0)U/L、AST 87.0(48.0, 233.0)vs. 52.0(31.0, 117.0)U/L,均P<0.05。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于智能计算法联合使用ISS与APACHE II评分在评估危重创伤患者早期肝损伤方面具有明显优势。
  • 危重创伤患者早期肝功能损害发生率高且可逆,入科6小时内应关注LDH、AST、ALT升高及ALB降低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the early changes in various liver function indicators in critically injured trauma patients assessed by intelligent calculation method, aiming to develop more advantageous diagnostic and treatment strategies for traumatic liver injury.

METHODS: A retrospective study was conducted. Critically injured trauma patients [injury severity score (ISS) ≥ 16, age > 18 years old] admitted to the Emergency Medical Center of Tianjin Fifth Central Hospital from January 1, 2022, to December 1, 2023 were enrolled. ISS score and acute physiology and chronic health evaluation II (APACHE II) assessed by intelligent calculation method were collected upon patient admission to the emergency medical center. Trends in liver function indicators in fasting venous serum were analyzed at 6, 24 and 72 hours after admission, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase (GGT), lactate dehydrogenase (LDH), albumin (ALB), total bilirubin (TBil), prothrombin time (PT). Patients were grouped based on APACHE II scores into those with APACHE II < 15 and APACHE II ≤ 15, and liver function indicators within 6 hours of admission were compared between the two groups.

RESULTS: A total of 112 critically injured trauma patients were included, with 83 males and 29 females, an average age of (47.78±14.84) years old. The median ISS score was 21.0 (18.0, 26.0). The most common cause of injury for critically injured trauma patients was road traffic accidents (68 cases, accounting for 60.71%), followed by falls from heights, compression injuries, heavy object injuries, knife stabs, and explosion injuries. The most common injured areas was the limbs and pelvis (97 cases, accounting for 86.61%), followed by chest injuries, surface skin and soft tissue injuries, abdominal and pelvic organ injuries, head injuries, and facial injuries. The proportion of elevated LDH, AST, and ALT within 6 hours of admission was 77.68%, 79.46%, and 52.68%, respectively, while the proportion of decreased ALB was 75.89%, the abnormal rates of ALP, GGT, TBil, and PT were all below 50%. The ALT and AST levels of patients at 24 hours and 72 hours after admission were significantly lower than those at 6 hours after admission [ALT (U/L): 37.0 (22.0, 66.0), 31.0 (21.2, 52.0) vs. 41.0 (25.0, 71.0), AST (U/L): 55.5 (30.0, 93.5), 40.0 (27.0, 63.2) vs. 69.5 (39.0, 130.8), all P < 0.05]. There was no statistically significant difference in ISS score between APACHE II > 15 group (45 cases) and APACHE II ≤ 15 group [67 cases; 21.0 (18.5, 26.5) vs. 20.0 (17.0, 22.0), P > 0.05]. Nevertheless, compared with patients with APACHE II ≤ 15, patients with APACHE II > 15 have a higher abnormality rate of ALT and AST within 6 hours of admission [ALT abnormal rate: 66.44% (29/45) vs. 44.78% (30/67), AST abnormal rate: 93.33% (42/45) vs. 70.15% (47/67), both P < 0.05], and the levels of ALT and AST were higher [ALT (U/L): 56.0 (30.0, 121.0) vs. 35.0 (21.0, 69.0), AST (U/L): 87.0 (48.0, 233.0) vs. 52.0 (31.0, 117.0), both P < 0.05].

CONCLUSIONS: Severe trauma patients frequently exhibit a high incidence of reversible early liver function impairment. Based on intelligent calculation method, the utilization of both the ISS and APACHE II scores demonstrates a distinct advantage in the assessment of their early liver injury.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Hou X, Zhao W, Li W, et al. [Early liver injury risk assessment in critically injured trauma patients using intelligent calculation method: a retrospective study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40017365. doi:10.3760/cma.j.cn121430-20240801-00653

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。